142 related articles for article (PubMed ID: 6284193)
1. Tumorigenicity and tumour-graft rejection of polyoma virus-transformed fibroblast-T-lymphocyte hybrids.
Foa C; Berebbi M; Lipcey C; Galindo JR; Bonneau H
Br J Exp Pathol; 1982 Jun; 63(3):305-14. PubMed ID: 6284193
[TBL] [Abstract][Full Text] [Related]
2. [Transmission and expression of malignancy in somatic hybrid cell lines (hamster/hamster, mouse/mouse, hamster/mouse)].
Berebbi M
Bull Cancer; 1976; 63(2):145-73. PubMed ID: 186142
[TBL] [Abstract][Full Text] [Related]
3. T-cell hybrids. III. Low tumorigenicity of hybrid cells derived from fusion of high tumorigenic (BW5147 X EL-4R) cell lines.
Bubeník J; Símová J
Folia Biol (Praha); 1982; 28(4):274-9. PubMed ID: 6982835
[TBL] [Abstract][Full Text] [Related]
4. T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance.
Dennert G; Anderson CG; Warner J
J Immunol; 1985 Dec; 135(6):3729-34. PubMed ID: 3905963
[TBL] [Abstract][Full Text] [Related]
5. [Expression of malignancy traits in the interspecific somatic hybrids of tumor and normal cells].
Kakpakova ES
Genetika; 1983 Nov; 19(11):1845-50. PubMed ID: 6317520
[TBL] [Abstract][Full Text] [Related]
6. Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity.
Halachmi E; Witz IP
Cancer Res; 1989 May; 49(9):2383-9. PubMed ID: 2539901
[TBL] [Abstract][Full Text] [Related]
7. Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophages.
Bosco MC; Musso T; Gusella GL; Giovarelli M; Forni M; Soleti A; Masuelli L; Modesti A; Forni G; Varesio L
J Immunol; 1993 Jan; 150(1):278-89. PubMed ID: 8417128
[TBL] [Abstract][Full Text] [Related]
8. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
9. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
Chen PW; Kaba DS; Ananthaswamy HN
Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specific immunity induced by somatic hybrids. I. Lack of relationship between immunogenicity and tumorigenicity of selected hybrids.
Kim BS; Liang W; Cohen EP
J Immunol; 1979 Aug; 123(2):733-8. PubMed ID: 88482
[TBL] [Abstract][Full Text] [Related]
11. [Somatic hybrids of normal and tumor Djzungarian hamster cells. II. Manifestation of malignancy and karyotype features of hybrid tumors].
Kakpakova ES; Malakhova EM; Massino IuS; Pogosiants EE
Genetika; 1980; 16(8):1380-8. PubMed ID: 6257592
[TBL] [Abstract][Full Text] [Related]
12. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
13. Hybrid cells formed by fusion of Epstein-Barr virus-associated B-lymphoblastoid cells and either marrow-derived or solid tumour-derived cell lines display different co-stimulatory phenotypes and abilities to activate allogeneic T-cell responses in vitro.
Cywinski AL; Dunnion DJ; Teobald I; Tucker VC; Browning MJ
Tissue Antigens; 2006 Aug; 68(2):115-26. PubMed ID: 16866881
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
Roberts LK
J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
[TBL] [Abstract][Full Text] [Related]
15. [Manifestation of malignancy in somatic hybrids obtained by the cell fusion of 2 tumor lines].
Kakpakova ES; Malakhova EM
Genetika; 1983 Jun; 19(6):975-80. PubMed ID: 6309611
[TBL] [Abstract][Full Text] [Related]
16. Differences in non-MHC alloantigens promote tissue rejection but fail to mediate allogeneic co-operation and autoimmunity in mice neonatally injected with semi-allogeneic F1 B cells.
Ramos A; Merino R; Merino J
Immunology; 1994 Jun; 82(2):287-93. PubMed ID: 7927500
[TBL] [Abstract][Full Text] [Related]
17. Inheritance of immunogenicity and metastatic potential in murine cell hybrids from the T-lymphoma ESb08 and normal spleen lymphocytes.
Larizza L; Schirrmacher V; Stöhr M; Pflüger E; Dzarlieva R
J Natl Cancer Inst; 1984 Jun; 72(6):1371-81. PubMed ID: 6610070
[TBL] [Abstract][Full Text] [Related]
18. Visualization of polyoma virus-specific CD8+ T cells in vivo during infection and tumor rejection.
Lukacher AE; Moser JM; Hadley A; Altman JD
J Immunol; 1999 Sep; 163(6):3369-78. PubMed ID: 10477607
[TBL] [Abstract][Full Text] [Related]
19. Augmentation of syngeneic tumor-specific immunity by semiallogeneic cell hybrids.
Toffaletti DL; Darrow TL; Scott DW
J Immunol; 1983 Jun; 130(6):2982-6. PubMed ID: 6189910
[TBL] [Abstract][Full Text] [Related]
20. [Protection afforded by hybrid cells against the inoculation of the parental tumour line (author's transl)].
Favre R; Filipczyk J; Berebbi M; Meyer G
Ann Immunol (Paris); 1974; 125(3):491-7. PubMed ID: 4369657
[No Abstract] [Full Text] [Related]
[Next] [New Search]
